Should You Buy Innospec Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Innospec Inc. (IOSP) is rated as a strong fundamental performer with a QOC score of 8.7/10. Trading at $91.82, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 3 of 12 CirclFi valuation models project upside for Innospec Inc. (IOSP) at $91.82 — the model consensus leans bearish, with a Quality Score of 8.7/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Innospec Inc. (IOSP) in 2026?
What Is the Bull Case vs the Bear Case for Innospec Inc. (IOSP)?
| Bull case — $214.76 target (+133.9%) | Bear case — $22.33 target (-75.7%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Innospec Inc.'s rating of 8.7/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. | According to the CirclFi Deep Alpha Valuation Engine, the Dynamic NAV model sees the stock as overvalued with a fair value of $22.33 (-75.7%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $214.76 (+133.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +209.6% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: aftermarket and services growth could provide meaningful support for Innospec Inc.'s revenue and margin trajectory in the Specialty Chemicals space. | Industry headwind: supply chain bottlenecks represents a meaningful risk for Innospec Inc. and its Specialty Chemicals peers. |
How Does IOSP Compare to Its Specialty Chemicals Peers?
Valuation data pages: HWKN · ECL · NEU · PPG · BCPC · AXTA · KOP · KRO · KBLB · ODC · RPM
Which Other Stocks Score Like IOSP on Quality?
Closest companies to IOSP’s Quality of Company score of 8.7/10, across all industries.
- ACIC — American Coastal Insurance Corporation (QOC 8.7) · analysis
- EFSC — Enterprise Financial Services Corp (QOC 8.7) · analysis
- QTWO — Q2 Holdings, Inc. (QOC 8.7) · analysis
- DCI — Donaldson Company, Inc. (QOC 8.7) · analysis
- MYRG — MYR Group Inc. (QOC 8.7) · analysis
- NLCP — NewLake Capital Partners, Inc. (QOC 8.7) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Specialty Chemicals Screens Does IOSP Appear In?
So Is Innospec Inc. (IOSP) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Innospec Inc. at $91.82. 9/12 models flag overvaluation, median fair value sits at $66.77 (-27.3%), and the risk-reward profile appears unfavorable. Quality at 8.7/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Innospec Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About IOSP Stock?
Should I buy IOSP stock right now?
Based on CirclFi's multi-model analysis, 3 of 12 models see upside for IOSP at $91.82. The models are divided, which means the investment case depends heavily on your assumptions about Innospec Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Innospec Inc.?
Key risks include: wide model disagreement (862% spread), signaling high uncertainty; general market and sector-specific risks affecting Specialty Chemicals companies. Always diversify and consult a financial advisor.
How does IOSP compare to its competitors?
Among Specialty Chemicals peers, IOSP holds a Quality Score of 8.7/10. Comparable companies include HWKN (QOC 8.8), ECL (QOC 8.7), NEU (QOC 8.8). The relative ranking helps investors identify whether IOSP offers better fundamental quality than alternatives in the same sector.
Is IOSP a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. IOSP's Quality Score of 8.7/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy IOSP at?
CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $22.33 to $214.76. At $91.82, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for IOSP.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad